Understanding the effects of Medicare Part D from key stakeholders' perspectives: Important progress, but abundant research opportunities remain.
Julie M
JM
Urmie
William R
WR
Doucette
D003157:Community Pharmacy Services / Q000191:economics / Q000458:organization & administration*; D032882:Comprehension; D003363:Cost Control; D016527:Drug Costs; D004608:Eligibility Determination; D018166:Health Care Reform; D006297:Health Services Accessibility / Q000191:economics / Q000458:organization & administration*; D006302:Health Services Research; D006801:Humans; D007182:Income; D019458:Insurance Coverage / Q000191:economics / Q000458:organization & administration*; D007356:Insurance, Pharmaceutical Services / Q000191:economics; D054524:Medicare Part D / Q000191:economics / Q000458:organization & administration*; D009937:Organizational Objectives; D055553:Prescription Drugs / Q000191:economics; D014481:United States
D055553:Prescription Drugs